Ubs Asset Management Americas Inc Kura Oncology, Inc. Transaction History

Ubs Asset Management Americas Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 122,668 shares of KURA stock, worth $1.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
122,668
Previous 125,104 1.95%
Holding current value
$1.11 Million
Previous $2.58 Million 6.95%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$18.57 - $23.23 $45,236 - $56,588
-2,436 Reduced 1.95%
122,668 $2.4 Million
Q2 2024

Aug 13, 2024
BUY
$17.53 - $22.98 $673,818 - $883,305
38,438 Added 44.35%
125,104 $2.58 Million
Q1 2024

May 15, 2024
BUY
$13.42 - $23.53 $64,550 - $113,179
4,810 Added 5.88%
86,666 $1.85 Million
Q3 2023

Nov 13, 2023
BUY
$8.44 - $11.86 $353,526 - $496,779
41,887 Added 104.8%
81,856 $746,000
Q1 2023

May 15, 2023
SELL
$10.71 - $14.6 $63,724 - $86,870
-5,950 Reduced 12.96%
39,969 $488,000
Q3 2022

Nov 14, 2022
SELL
$12.01 - $19.45 $3.54 Million - $5.73 Million
-294,543 Reduced 86.51%
45,919 $627,000
Q2 2022

Aug 12, 2022
SELL
$10.71 - $18.33 $107,838 - $184,564
-10,069 Reduced 2.87%
340,462 $6.24 Million
Q1 2022

May 16, 2022
SELL
$11.78 - $16.98 $249,959 - $360,298
-21,219 Reduced 5.71%
350,531 $5.64 Million
Q4 2021

Feb 14, 2022
SELL
$12.22 - $19.57 $139,124 - $222,804
-11,385 Reduced 2.97%
371,750 $5.2 Million
Q3 2021

Nov 15, 2021
SELL
$15.42 - $21.72 $146,921 - $206,948
-9,528 Reduced 2.43%
383,135 $7.18 Million
Q2 2021

Aug 16, 2021
BUY
$20.85 - $29.88 $1.93 Million - $2.77 Million
92,687 Added 30.9%
392,663 $8.19 Million
Q1 2021

May 14, 2021
BUY
$24.75 - $39.14 $1.01 Million - $1.59 Million
40,660 Added 15.68%
299,976 $8.48 Million
Q4 2020

Mar 01, 2021
BUY
$29.0 - $41.62 $6.4 Million - $9.18 Million
220,616 Added 570.07%
259,316 $8.47 Million
Q3 2020

Nov 13, 2020
BUY
$16.3 - $30.64 $7,498 - $14,094
460 Added 1.2%
38,700 $1.19 Million
Q2 2020

Aug 14, 2020
BUY
$7.95 - $18.81 $180,655 - $427,438
22,724 Added 146.46%
38,240 $623,000
Q1 2020

May 15, 2020
SELL
$6.45 - $14.04 $53,386 - $116,209
-8,277 Reduced 34.79%
15,516 $154,000
Q4 2019

Feb 14, 2020
BUY
$12.97 - $15.94 $1,569 - $1,928
121 Added 0.51%
23,793 $327,000
Q3 2019

Nov 14, 2019
BUY
$14.75 - $20.87 $349,162 - $494,034
23,672 New
23,672 $359,000

Others Institutions Holding KURA

# of Institutions
185
Shares Held
81.8M
Call Options Held
42.1K
Put Options Held
34K
View Full List

About Kura Oncology, Inc.

KURA Quotes by TradingView
  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $603M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email